Lv1
34 积分 2023-05-21 加入
Predictors of fibrosis, clinical events and mortality in MASLD: Data from the Global-MASLD study
1个月前
已完结
Semaglutide in NASH-related cirrhosis: too late to the party?
6个月前
已完结
Efficacy of peroxisome proliferator-activated receptor agonists, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors for treatment of non-alcoholic fatty liver disease: a systematic review
6个月前
已完结
Long-term liver-related outcomes and liver stiffness progression of statin usage in steatotic liver disease
6个月前
已完结
Building the AI-Enabled Medical School of the Future
7个月前
已完结
皖公网安备34019202002308
